Merck
MRK
#47
Rank
HK$2.385 T
Marketcap
HK$964.76
Share price
3.27%
Change (1 day)
54.48%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$57.00

According to Merck's latest financial reports the company's current EPS (TTM) is HK$57.26. an increase over its 2024 EPS that were of HK$52.94.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025HK$57.027.71%
2024HK$52.944308.46%
2023HK$1.20-97.32%
2022HK$44.8810.92%
2021HK$40.4684.68%
2020HK$21.91-27.2%
2019HK$30.0963.44%
2018HK$18.41151.11%
2017HK$7.33-54.58%
2016HK$16.1430.21%
2015HK$12.40-61.99%
2014HK$32.61180.51%
2013HK$11.63-31.82%
2012HK$17.056.62%
2011HK$15.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.24 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.39-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.37-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.33 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.23 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.17-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.10-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.51-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.71-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel